Zou Z, Anisowicz A, Hendrix M J, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E, Sager R
Division of Cancer Genetics, Dana-Farber Cancer Institute, Boston, MA 02115.
Science. 1994 Jan 28;263(5146):526-9. doi: 10.1126/science.8290962.
A gene encoding a protein related to the serpin family of protease inhibitors was identified as a candidate tumor suppressor gene that may play a role in human breast cancer. The gene product, called maspin, is expressed in normal mammary epithelial cells but not in most mammary carcinoma cell lines. Transfection of MDA-MB-435 mammary carcinoma cells with the maspin gene did not alter the cells' growth properties in vitro, but reduced the cells' ability to induce tumors and metastasize in nude mice and to invade through a basement membrane matrix in vitro. Analysis of human breast cancer specimens revealed that loss of maspin expression occurred most frequently in advanced cancers. These results support the hypothesis that maspin functions as a tumor suppressor.
一种编码与丝氨酸蛋白酶抑制剂家族相关蛋白质的基因被鉴定为候选肿瘤抑制基因,该基因可能在人类乳腺癌中发挥作用。这种基因产物被称为乳腺丝抑蛋白(maspin),在正常乳腺上皮细胞中表达,但在大多数乳腺癌细胞系中不表达。用maspin基因转染MDA-MB-435乳腺癌细胞,在体外并未改变细胞的生长特性,但降低了细胞在裸鼠体内诱导肿瘤和转移以及在体外穿透基底膜基质的能力。对人类乳腺癌标本的分析显示,maspin表达缺失在晚期癌症中最为常见。这些结果支持了maspin作为肿瘤抑制因子发挥作用的假说。